Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
ARS Pharmaars-pharma.com · Low evidenceARS Pharma develops patient-friendly therapies that reduce needle-related risks and improve portability and ease of use. Its flagship product neffy is an epinephrine nasal spray, marketed as the first and only FDA-approved needle-free epinephrine product. The company provides savings and support programs for patients and caregivers and offers resources such as neffyConnect and prescribing information.
Parse Score